Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name JNJ 38877605
Trade Name
Synonyms JNJ38877605|JNJ-38877605
Drug Descriptions

JNJ 38877605 binds to MET and prevents its activation, resulting in decreased downstream signaling and potentially resulting in increased cell death of MET-overexpressing tumor cells (PMID: 31881189, PMID: 30284817).

DrugClasses MET Inhibitor 59
CAS Registry Number 943540-75-8
NCIT ID C77893


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cetuximab + JNJ 38877605 Cetuximab JNJ 38877605 0 0
JNJ 38877605 JNJ 38877605 0 0
JNJ 38877605 + Olaparib JNJ 38877605 Olaparib 0 0
JNJ 38877605 + Panitumumab JNJ 38877605 Panitumumab 0 0

Additional content available in CKB BOOST